Drittanti; Lila

Patent Applications and Registrations

Patent applications and USPTO patent grants for Drittanti; Lila.The latest application filed is for "modified coagulation factor ix polypeptides and use thereof for treatment".

Company Profile

0.16.37

Drittanti; Lila - Vigneux-sur-Seine FR
Drittanti; Lila - Bahia Blanca AR
Drittanti; Lila - Vigneux sur Siene FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified coagulation factor IX polypeptides and use thereof for treatment App 20130243855 - Oyhenart; Jorge ; et al.	2013-09-19
Gametes Separation Methods, Compositions And Uses Thereof App 20130130263 - Vega; Manuel ; et al.	2013-05-23
Modified coagulation factor IX polypeptides and use thereof for treatment Grant 8,383,388 - Oyhenart , et al. February 26, 2	2013-02-26
Modified Erythropoietin (epo) Polypeptides That Exhibit Increased Protease Resistance And Pharmaceutical Compositions Thereof App 20120264686 - Guyon; Thierry ; et al.	2012-10-18
Modified erythropoietin polypeptides and uses thereof for treatment Grant 8,252,743 - Guyon , et al. August 28, 2	2012-08-28
Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof Grant 8,222,209 - Guyon , et al. July 17, 2	2012-07-17
Modified Erythropoietin (epo) Polypeptides That Exhibit Increased Protease Resistance And Pharmaceutical Compositions Thereof App 20120094906 - Guyon; Thierry ; et al.	2012-04-19
Protease resistant modified erythropoietin polypeptides Grant 8,114,839 - Gantier , et al. February 14, 2	2012-02-14
Protease resistant modified IFN beta polypeptides and their use in treating diseases Grant 8,105,573 - Gantier , et al. January 31, 2	2012-01-31
HMGB1 high affinity binding domain Box-A mutants Grant 8,058,232 - Fumero , et al. November 15, 2	2011-11-15
Protease resistant modified interferon-beta polypeptides Grant 8,057,787 - Gantier , et al. November 15, 2	2011-11-15
Interferon-.beta. mutants with increased anti-proliferative activity Grant 8,052,964 - Gantier , et al. November 8, 2	2011-11-08
Modified growth hormones Grant 7,998,930 - Guyon , et al. August 16, 2	2011-08-16
Protease resistant interferon beta mutants Grant 7,998,469 - Gantier , et al. August 16, 2	2011-08-16
Protease Resistant Modified Interferon-beta Polypeptides And Their Use In Treating Diseases App 20110142801 - GANTIER; Rene ; et al.	2011-06-16
Modified growth hormones App 20110130331 - Guyon; Thierry ; et al.	2011-06-02
Use Of Polypeptides Obtained Through Systematic Mutations Of Single Amino Acids Of Human And Non-human Box-a Of Hmgb1 To Prevent And/or Antagonize Pathologies Induced By Hmgb1 App 20110052493 - FUMERO; Silvano ; et al.	2011-03-03
Modified growth hormone Grant 7,884,073 - Guyon , et al. February 8, 2	2011-02-08
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules Grant 7,650,243 - Gantier , et al. January 19, 2	2010-01-19
High throughput directed evolution by rational mutagenesis Grant 7,647,184 - Vega , et al. January 12, 2	2010-01-12
Protease resistant mutant of human HMGB1 high affinity binding domain Box-A (HMGB1 Box-A) Grant 7,635,679 - Fumero , et al. December 22, 2	2009-12-22
Protease resistant modified interferon alpha polypeptides Grant 7,611,700 - Gantier , et al. November 3, 2	2009-11-03
Modified erythropoietin polypeptides and uses thereof App 20090238789 - Guyon; Thierry ; et al.	2009-09-24
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20090131318 - Gantier; Rene ; et al.	2009-05-21
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20090123974 - Gantier; Rene ; et al.	2009-05-14
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20090053147 - Gantier; Rene ; et al.	2009-02-26
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20080274081 - Gantier; Rene ; et al.	2008-11-06
Oral dosage formulations of protease-resistant polypeptides App 20080260820 - Borrelly; Gilles ; et al.	2008-10-23
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20080194477 - Gantier; Rene ; et al.	2008-08-14
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20080159977 - Gantier; Rene ; et al.	2008-07-03
Modified coagulation factor IX polypeptides and use thereof for treatment App 20080102115 - Oyhenart; Jorge ; et al.	2008-05-01
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20080075672 - Gantier; Rene ; et al.	2008-03-27
Modified interferon-beta (IFN-beta) polypeptides App 20080038224 - Guyon; Thierry ; et al.	2008-02-14
Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human Box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1 App 20080038309 - Fumero; Silvano ; et al.	2008-02-14
Modified growth hormones App 20080026993 - Guyon; Thierry ; et al.	2008-01-31
Modified interferon-beta (IFN-beta) polypeptides App 20080003202 - Guyon; Thierry ; et al.	2008-01-03
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20070254838 - Gantier; Rene ; et al.	2007-11-01
Modified growth hormones App 20070249532 - Guyon; Thierry ; et al.	2007-10-25
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20070224665 - Gantier; Rene ; et al.	2007-09-27
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20070172459 - Gantier; Rene ; et al.	2007-07-26
Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides App 20060251619 - Borrelly; Gilles ; et al.	2006-11-09
Modified growth hormones App 20060247170 - Guyon; Thierry ; et al.	2006-11-02
Modified growth hormones App 20060094655 - Guyon; Thierry ; et al.	2006-05-04
Rational directed protein evolution using two-dimensional rational mutagenesis scanning App 20060020396 - Gantier; Rene ; et al.	2006-01-26
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20060020116 - Gantier; Rene ; et al.	2006-01-26
Rational directed protein evolution using two-dimensional rational mutagenesis scanning App 20050202438 - Gantier, Rene ; et al.	2005-09-15
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules App 20040132977 - Gantier, Rene ; et al.	2004-07-08
High throughput directed evolution of nucleic acids by rational mutagenesis App 20030224404 - Vega, Manuel ; et al.	2003-12-04
High throughput directed evolution by rational mutagenesis App 20030134351 - Vega, Manuel ; et al.	2003-07-17
Mutant recombinant adeno-associated viruses App 20030129203 - Vega, Manuel ; et al.	2003-07-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.